EAGLE-1 trial data shows gepotidacin’s potential in treating gonorrhoea, for which no new antibiotics have been approved ...

For uncomplicated urogenital gonorrhea, gepotidacin, which inhibits bacterial DNA replication, is noninferior to ceftriaxone ...

A new study published in the journal of The Lancet showed that, with no new safety issues, gepotidacin showed no inferiority ...

The appendix is thought to play a role in all of this by producing inflammatory proteins that trigger the body to produce ...

A novel antibiotic recently approved for treatment of urinary tract infections also shows efficacy against gonorrhea, ...

Gonorrhea is on the verge of incurability, with just one antibiotic that still reliably works against the sexually ...

Gonorrhoea, a sexually transmitted infection (STI) caused by Neisseria gonorrhoeae, remains a major public health threat globally. In 2020, WHO estimated 82·4 million new global gonorrhoea cases among ...

A new type of antibiotic for treatment of urinary tract infections in women could also work against gonorrhea infections, a ...

Our Sexual Health programs and services follow the Ontario Public Health Standards. Ceftriaxone 500 mg IM as a single dose (monotherapy) for all uncomplicated infections (urethral, endocervical, ...

While most gonorrhoea infections can be effectively treated, certain resistant strains, particularly ceftriaxone-resistant gonorrhoea, present a much greater challenge. As the primary antibiotic ...

But UKHSA said it was growing concerned over a small number of cases that weren't responding to ceftriaxone - an antibiotic used as the first line of treatment for gonorrhoea. For some ...